Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | GRHL2 |
| Upstream (Parents) |
|---|
| (<<) PTTG1 → GRHL2 |
| (<<) CSRNP3 → GRHL2 |
| (<<) MAF → GRHL2 |
| (<<) MEIS1 → GRHL2 |
| (<<) KLF9 → GRHL2 |
| (<<) HOXA7 → GRHL2 |
| (<<) MEF2C → GRHL2 |
| (<<) RARA → GRHL2 |
| (<<) HSF1 → GRHL2 |
| (<<) HMGA1 → GRHL2 |
| (<<) RORA → GRHL2 |
| (<<) NR2F6 → GRHL2 |
| (<<) GATAD2A → GRHL2 |
| Downstream (Children) |
|---|
| GRHL2 → TFAP2B (>>) |
| GRHL2 → IRX1 (>>) |
| GRHL2 → HLF (>>) |
| GRHL2 → HOXC13 (>>) |
| GRHL2 → CDKN2A (>>) |
| GRHL2 → NR3C1 (>>) |
| GRHL2 → TP53 (>>) |
| GRHL2 → TULP4 (>>) |
| GRHL2 → NFIL3 (>>) |
| GRHL2 → PAX6 (>>) |
| GRHL2 → TEF (>>) |
| GRHL2 → DRAP1 (>>) |
| GRHL2 → IRX4 (>>) |
| GRHL2 → ARID4A (>>) |
